Reducing the risk of recurrences after pulmonary vein isolation: what is the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers?

Cardiology. 2010;117(1):11-3. doi: 10.1159/000320069. Epub 2010 Sep 29.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / epidemiology
  • Atrial Fibrillation* / surgery
  • Catheter Ablation / methods*
  • Combined Modality Therapy
  • Humans
  • Pulmonary Veins / surgery*
  • Risk Factors
  • Secondary Prevention

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors